Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Income from Continuing Operations (2020 - 2026)

SkinHealth Systems has reported Income from Continuing Operations over the past 6 years, most recently at 8104000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 21.55% to 8104000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9533000.0 through Dec 2025, up 67.24% year-over-year, with the annual reading at 9519000.0 for FY2025, 67.29% up from the prior year.
  • Income from Continuing Operations was 8104000.0 for Q4 2025 at SkinHealth Systems, up from 11045000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 31455000.0 in Q1 2022 and troughed at 215145000.0 in Q3 2021.
  • The 5-year median for Income from Continuing Operations is 8753500.0 (2023), against an average of 23661000.0.
  • Year-over-year, Income from Continuing Operations crashed 91033.33% in 2023 and then surged 9658.42% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 20967000.0 in 2021, then surged by 131.3% to 6563000.0 in 2022, then tumbled by 243.27% to 9403000.0 in 2023, then decreased by 9.86% to 10330000.0 in 2024, then rose by 21.55% to 8104000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Income from Continuing Operations are 8104000.0 (Q4 2025), 11045000.0 (Q3 2025), and 19712000.0 (Q2 2025).